Case studies and cost-benefit analysis of HER2 and TPMT in four EU member states: part two of an ESTO study on pharmacogenetics and pharmacogenomics: state of the art and social economic impacts
report
JPB
Topics
TNO Identifier
274908
Publisher
Office for Official Publications of the European Communities
Place of publication
Luxembourg